Point72 Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.9M Sell
2,127,467
-1,881,233
-47% -$17.6M 0.04% 421
2025
Q1
$49.2M Buy
4,008,700
+2,092,964
+109% +$25.7M 0.11% 206
2024
Q4
$25.3M Sell
1,915,736
-862,531
-31% -$11.4M 0.06% 343
2024
Q3
$53.5M Sell
2,778,267
-4,586
-0.2% -$88.3K 0.14% 163
2024
Q2
$57.1M Buy
2,782,853
+716,168
+35% +$14.7M 0.15% 180
2024
Q1
$49.2M Sell
2,066,685
-767,814
-27% -$18.3M 0.12% 195
2023
Q4
$61.3M Buy
2,834,499
+740,298
+35% +$16M 0.15% 170
2023
Q3
$30.4M Buy
2,094,201
+859,401
+70% +$12.5M 0.09% 271
2023
Q2
$25.8M Buy
1,234,800
+710,400
+135% +$14.9M 0.08% 294
2023
Q1
$11.1M Sell
524,400
-399,000
-43% -$8.43M 0.03% 468
2022
Q4
$23.5M Buy
+923,400
New +$23.5M 0.08% 288
2022
Q2
Sell
-360,000
Closed -$6.26M 1313
2022
Q1
$6.26M Buy
360,000
+6,900
+2% +$120K 0.02% 589
2021
Q4
$7.73M Sell
353,100
-107,800
-23% -$2.36M 0.03% 547
2021
Q3
$8.81M Buy
460,900
+148,500
+48% +$2.84M 0.04% 491
2021
Q2
$5.36M Sell
312,400
-634,400
-67% -$10.9M 0.02% 556
2021
Q1
$21.2M Sell
946,800
-197,100
-17% -$4.41M 0.1% 240
2020
Q4
$25.4M Buy
1,143,900
+977,863
+589% +$21.7M 0.12% 215
2020
Q3
$2.45M Buy
+166,037
New +$2.45M 0.01% 628
2018
Q4
Sell
-170,000
Closed -$1.37M 1044
2018
Q3
$1.37M Buy
+170,000
New +$1.37M 0.01% 665
2018
Q2
Sell
-300,000
Closed -$4.27M 985
2018
Q1
$4.27M Buy
+300,000
New +$4.27M 0.02% 493
2017
Q2
Sell
-99,000
Closed -$1.36M 868
2017
Q1
$1.36M Buy
+99,000
New +$1.36M 0.01% 628